Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01933789 · ClinicalTrials.gov registry record · NA
Improving Communication About Serious Illness
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 817
- Enrollment target
NCT01933789: Completed NA study, sponsored by University of Washington.
NCT01933789 is a NA study that has completed, run by University of Washington. The registered enrollment target is 817 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01933789, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 817 participants
- Enrollment target
Study Summary
The purpose of this study is to improve care delivered to patients with serious illness by enhancing communication among patients, families, and clinicians in the outpatient setting. We are testing a new way to help patients share their preferences for talking about end-of-life care with their clinicians and families. To do this we created a simple, short feedback form. The form is designed to help clinicians understand what patients would like to talk about. The goal of this research study is to show that using a feedback form is possible and can be helpful for patients and their families.
Primary Outcome
Patient's response to question, "Did you discuss with this doctor the kind of medical care you would want if you were too sick to speak for yourself?"
Interventions
- BEHAVIORAL Communication Feedback Form for Patients with Serious Illness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 817 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT01933789 record still lists
NCT01933789 is an interventional study that assigns participants to a tested intervention. The registered 817 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 1 intervention - of which Communication Feedback Form for Patients with Serious Illness is the first listed.
NCT01933789 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01933789 about?
NCT01933789 is a clinical study titled "Improving Communication About Serious Illness". The purpose of this study is to improve care delivered to patients with serious illness by enhancing communication among patients, families, and clinicians in the outpatient setting. We are testing a new way to help patients share their preferences for talking about end-of-life care with their clini...
What is the current status of trial NCT01933789?
This trial is currently completed. It is a NA study. The enrollment target is 817 participants. The study started on 2013-09. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01933789?
The interventions under investigation include: Communication Feedback Form for Patients with Serious Illness (BEHAVIORAL).
Who is sponsoring clinical trial NCT01933789?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01933789's enrollment target sits among peer trials
817 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- NCT07218029 · 815 participants · Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
- NCT04613440 · 820 participants · NA
FaCT Trial (Facilitated Cascade Testing Trial)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia